Insulet Corp PODD

Morningstar Rating

Insulet Gears Up to Face Heightened Competition in 2027

Business Strategy and Outlook

With little direct competition in patch pumps for two decades, Insulet has been able to convert more users, especially patients on multiple daily injections, to its innovative, tubeless insulin pump. The firm has carved a path to meaningful profitability gains.

Sponsor Center